| Lori Ann Yeager, | |
|
101 S Moore Ave, Claremore, OK 74017-5047 | |
| (918) 342-6495 | |
| Not Available |
| Full Name | Lori Ann Yeager |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Emergency |
| Location | 101 S Moore Ave, Claremore, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154885168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WE0003X | Registered Nurse - Emergency | 71394 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Ann Yeager, 101 S Moore Ave, Claremore, OK 74017-5091 Ph: (918) 342-6495 | Lori Ann Yeager, 101 S Moore Ave, Claremore, OK 74017-5047 Ph: (918) 342-6495 |
News Archive
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements.
People who are pregnant, breastfeeding or trying to conceive should be offered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine based on ethical grounds, argue authors of a commentary in CMAJ (Canadian Medical Association Journal).
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds outperformed market leader Roche's drug Ganciclovir in cell culture and plaque reduction assay (the gold standard) for Cytomegalovirus (CMV) disease. Additionally, antiviral activity was also apparent against other human herpesviruses, namely, HSV-1 (cold sores), HSV-2 (genital herpes), and Varicella-Zoster Virus (VZV) (chicken-pox and shingles).
› Verified 5 days ago
Sheila Upton, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6495 | |
Amanda Starr Gibson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6000 | |
Inger M Taylor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6000 | |
Mary Lou Kennedy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6295 Fax: 918-342-6508 | |
Mary Sue Bailey, RN CIC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6200 | |
Ms. Debra Louise Harlow, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12005 E 470 Rd, Claremore, OK 74017 Phone: 918-342-0770 Fax: 918-342-0087 | |
Emily Shearer, APRN-CNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 17599 S Highway 88, Claremore, OK 74017 Phone: 918-342-8161 Fax: 918-341-4245 |